VARIABILITY IN THE DISPOSITION OF CHLORZOXAZONE

Chlorzoxazone is 6-hydroxylated by cytochrome P450 2E1 (CYP 2E1), whic h bioactivates many toxic and carcinogenic molecules. Seventeen volunt eers of varying age, ethnicity, and gender received a 250 mg tablet of chlorzoxazone and their blood and urine were sampled frequently for 8 h. V/F = 42 +/- 21 L and CL/F = 412 +/- 120 mL min(-1). Comparison of these values with a study by other investigators using a suspension d osage form suggested that relative F(tablet)similar to 0.7. The fracti on excreted in the urine as 6-hydroxychlorzoxazone (f(e,6-OH)) was 0.3 9 +/- 0.20 and that portion of the total CL accounted for by CYP 2E1-m ediated metabolism (CL(6-OH)) was 163 +/- 95 mL min(-1). Thus, while V /F and CL/F varied by factors of less than five, f(e,6-OH) varied 16-f old and CL(6-OH) varied 28-fold. These results suggested that there wa s considerable inter-individual variability in the metabolism of chlor zoxazone to 6-hydroxychlorzoxazone. This variability will significantl y affect the construction of physiologically based pharmacokinetic mod els that use the 6-hydroxylation of chlorzoxazone as a marker for an i ndividual's CYP 2E1 phenotype.